Literature DB >> 22608157

Functional interactions of HIV-infection and methamphetamine dependence during motor programming.

Sarah L Archibald1, Mark W Jacobson, Christine Fennema-Notestine, Miki Ogasawara, Steven P Woods, Scott Letendre, Igor Grant, Terry L Jernigan.   

Abstract

Methamphetamine (METH) dependence is frequently comorbid with HIV infection and both have been linked to alterations of brain structure and function. In a previous study, we showed that the brain volume loss characteristic of HIV infection contrasts with METH-related volume increases in striatum and parietal cortex, suggesting distinct neurobiological responses to HIV and METH (Jernigan et al., 2005). Functional magnetic resonance imaging (fMRI) has the potential to reveal functional interactions between the effects of HIV and METH. In the present study, 50 participants were studied in four groups: an HIV+ group, a recently METH-dependent group, a dually affected group, and a group of unaffected community comparison subjects. An fMRI paradigm consisting of motor sequencing tasks of varying levels of complexity was administered to examine blood oxygenation level dependent (BOLD) changes. Within all groups, activity increased significantly with increasing task complexity in large clusters within sensorimotor and parietal cortex, basal ganglia, cerebellum, and cingulate. The task complexity effect was regressed on HIV status, METH status, and the HIV×METH interaction term in a simultaneous multiple regression. HIV was associated with less complexity-related activation in striatum, whereas METH was associated with less complexity-related activation in parietal regions. Significant interaction effects were observed in both cortical and subcortical regions; and, contrary to expectations, the complexity-related activation was less aberrant in dually affected than in single risk participants, in spite of comparable levels of neurocognitive impairment among the clinical groups. Thus, HIV and METH dependence, perhaps through their effects on dopaminergic systems, may have opposing functional effects on neural circuits involved in motor programming.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22608157      PMCID: PMC3380171          DOI: 10.1016/j.pscychresns.2012.03.006

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  40 in total

1.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

2.  HIV-associated cognitive impairment before and after the advent of combination therapy.

Authors:  Ned Sacktor; Michael P McDermott; Karen Marder; Giovanni Schifitto; Ola A Selnes; Justin C McArthur; Yaakov Stern; Steve Albert; Donna Palumbo; Karl Kieburtz; Joy A De Marcaida; Bruce Cohen; Leon Epstein
Journal:  J Neurovirol       Date:  2002-04       Impact factor: 2.643

3.  Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity.

Authors:  Matthew J LaVoie; J Patrick Card; Teresa G Hastings
Journal:  Exp Neurol       Date:  2004-05       Impact factor: 5.330

4.  The impact of HIV-associated neuropsychological impairment on everyday functioning.

Authors:  Robert K Heaton; Thomas D Marcotte; Monica Rivera Mindt; Joseph Sadek; David J Moore; Heather Bentley; J Allen McCutchan; Carla Reicks; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2004-05       Impact factor: 2.892

5.  Structural abnormalities in the brains of human subjects who use methamphetamine.

Authors:  Paul M Thompson; Kiralee M Hayashi; Sara L Simon; Jennifer A Geaga; Michael S Hong; Yihong Sui; Jessica Y Lee; Arthur W Toga; Walter Ling; Edythe D London
Journal:  J Neurosci       Date:  2004-06-30       Impact factor: 6.167

6.  Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons.

Authors:  Julie D Rippeth; Robert K Heaton; Catherine L Carey; Thomas D Marcotte; David J Moore; Raul Gonzalez; Tanya Wolfson; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2004-01       Impact factor: 2.892

7.  Abnormal contingent negative variation in HIV patients receiving antiretroviral therapy.

Authors:  Linda L Chao; Valerie A Cardenas; Dieter J Meyerhoff; Johannes C Rothlind; Derek L Flenniken; Joselyn A Lindgren; Michael W Weiner
Journal:  Neuroreport       Date:  2003-11-14       Impact factor: 1.837

Review 8.  Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review.

Authors:  Thomas E Nordahl; Ruth Salo; Martin Leamon
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2003       Impact factor: 2.198

9.  Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss.

Authors:  Sarah L Archibald; Eliezer Masliah; Christine Fennema-Notestine; Thomas D Marcotte; Ronald J Ellis; J Allen McCutchan; Robert K Heaton; Igor Grant; Margaret Mallory; Aida Miller; Terry L Jernigan
Journal:  Arch Neurol       Date:  2004-03

10.  Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment--an oligonucleotide microarray approach.

Authors:  David M Thomas; Dina M Francescutti-Verbeem; Xiuli Liu; Donald M Kuhn
Journal:  J Neurochem       Date:  2004-01       Impact factor: 5.372

View more
  6 in total

1.  Everyday functional ability in HIV and methamphetamine dependence.

Authors:  Arpi Minassian; Brook L Henry; Jennifer E Iudicello; Erin E Morgan; Scott L Letendre; Robert K Heaton; William Perry
Journal:  Drug Alcohol Depend       Date:  2017-03-28       Impact factor: 4.492

2.  "Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency.

Authors:  María J Marquine; Jennifer E Iudicello; Erin E Morgan; Gregory G Brown; Scott L Letendre; Ronald J Ellis; Reena Deutsch; Steven Paul Woods; Igor Grant; Robert K Heaton
Journal:  Psychiatry Res       Date:  2013-11-13       Impact factor: 3.222

Review 3.  Neuroimmune basis of methamphetamine toxicity.

Authors:  Jennifer M Loftis; Aaron Janowsky
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

4.  HIV/AIDS and an overweight body mass are associated with excessive intra-individual variability in response preparation.

Authors:  Lance O Bauer
Journal:  J Neurovirol       Date:  2018-05-17       Impact factor: 2.643

5.  Cerebrospinal Fluid Norepinephrine and Neurocognition in HIV and Methamphetamine Dependence.

Authors:  Rowan Saloner; Mariana Cherner; Jennifer E Iudicello; Robert K Heaton; Scott L Letendre; Ronald J Ellis
Journal:  J Acquir Immune Defic Syndr       Date:  2020-10-01       Impact factor: 3.771

6.  Prior Methamphetamine Use Disorder History Does Not Impair Interoceptive Processing of Soft Touch in HIV Infection.

Authors:  Amanda Bischoff-Grethe; Ronald J Ellis; Susan F Tapert; Martin P Paulus; Igor Grant
Journal:  Viruses       Date:  2021-12-10       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.